FDA warns Zocor, Vytorin raise muscle injury risk - MarketWatch
Become a MarketWatch member today
 March 19, 2010, 11:37 a.m. EDT 
FDA warns Zocor, Vytorin raise muscle injury risk
Explore related topics
 Biotechnology 
 Pharmaceuticals 
 Merck & Co Inc New 
 Pfizer Inc 
 By Val Brickates Kennedy 
 BOSTON (MarketWatch) -- The U.S. Food and Drug Administration warned Friday that high doses of the popular cholesterol-controlling drugs Zocor and Vytorin could increase the risk of developing rhabdomyolysis, an extremely serious muscle injury that can sometimes lead to death . Both Zocor and Vytorin are marketed by Merck & Co. 
/quotes/comstock/13*!mrk
. Zocor, also known as simvastin, belongs to a class of cholesterol drugs called statins, which includes such popular medications as Pfizer Inc.'s 
/quotes/comstock/13*!pfe
 Lipitor and AstraZeneca PLC's 
/quotes/comstock/13*!azn
 Crestor. Vytorin is a combination of Zocor and a non-statin drug called Zetia. Zocor is also a component of the product Simcor. The agency noted that statin drugs already carry a warning that they could make users susceptible to muscle injuries. 
Most Recent Market Pulse
Shareholder sues Goldman Sachs board: report
U.S. stocks end session, week on upbeat note
Lions Gate amends shareholder rights plan
S&P; raises Mattel's long-term rating to 'BBB'
Oil builds on housing bounce to finish higher
U.S. suspects Goldman tip-off on Buffett deal: WSJ
New-home sales surge 27% to 411,000 pace
Apple passes Microsoft on S&P 500 market cap list
Greece gives up, formally requests rescue
U.S. stock futures retain slight edge after data
You will be much amazed when the gov will tell you, &quot;Sorry, the treatment you want is too expensive, we recommend amputation&quot;. Then you will praise again the ones that know what's best for you !&quot;
10:47 a.m. March 19, 2010
+1 Vote (1 Up / 0 Down)
MarketWatch's Latest Tweets
"Defining 'last activity' on a credit report: Plus more credit report help, including how to dispute an inaccuracy 
3:59 p.m. EDT, April 23, 2010 from 
"Raters were overwhelmed, understaffed and pressured by banks, panel reveals 
3:34 p.m. EDT, April 23, 2010 from 
"U.S. stocks gain Friday; Dow's 8-week win streak is longest since 2004 
3:04 p.m. EDT, April 23, 2010 from 
"German business climate best in nearly two years 
12:54 p.m. EDT, April 23, 2010 from 
"Psst -- N.Y. Times, you're in the wrong business 
12:35 p.m. EDT, April 23, 2010 from 
/quotes/comstock/13*!mrk
Merck & Co Inc New (MRK)
/marketstate/country/
The market is closed
/quotes/comstock/13*!pfe
/marketstate/country/
The market is closed
/quotes/comstock/13*!azn
AstraZeneca PLC (AZN)
/marketstate/country/
The market is closed
/marketstate/country/us
/marketstate/country/uk
/marketstate/country/jp
/marketstate/country/us
/marketstate/country/uk
/marketstate/country/jp
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166575
2010 Hyundai Tucson: Home-run swing falls short
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166574
Money Markets and More, Monday, April 26 Preview
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166573
Inspector: SEC staff watched porn during crisis
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166571
Financial stocks hold onto weekly gains
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166569
Washington events for April 26 - 30
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166568
U.S. stocks end higher, led by energy stocks
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166566
Dream Kitchen on a Budget
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166565
MarketEdge: Not All Derivatives Are For Exchanges
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166561
Palm shares up, Amazon slips in evening session
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166559
Exelon profit up 5%, raises low end of 2010 view
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166557
Schlumberger stock surges on upbeat outlook
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166555
MarketWatch's Take On Tech For April 23
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166553
Western Digital shares jump on strong profit gain
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166550
Oil service, natural gas shares touch new highs
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166548
Texas Instruments expected to post 50% sales gain
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166547
Shareholder sues Goldman Sachs board: report
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166546
Closing bell from MarketWatch Radio Network
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166545
Western Digital leads gains across tech sector
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166543
Asia's Week Ahead: Earnings, Japan data in focus
8c077dc4-5ad2-4f73-b9c3-a381c5fece05:166542
U.S. stocks end session, week on upbeat note
Loading more headlines...
/quotes/comstock/10w!i:dji/delayed
/quotes/comstock/10y!i:comp
/quotes/comstock/21z!i1:in\x
Email address or display name
The action you requested requires a MarketWatch Community display name.
Email address or display name
Get your FREE membership now »
 MarketWatch Community is a free service that lets you discover, organize and share MarketWatch stories with other readers.
The action you requested is only available to MarketWatch members.
Please sign in or register.
Email address or display name
Don't have a MarketWatch account?
Get your FREE membership now »
 By registering, you are agreeing to MarketWatch's Terms of Service and to receiving periodic news and special offers via email about MarketWatch enhancements, products and services. 
